Parallel clinical investigations will correlate BLOC1S1 polymorphisms with disease progression in brucellosis and TDP‐43 proteinopathy cohorts, bridging fundamental mechanisms to precision medicine applications across infectious and neurodegenerative diseases. Here, TARDBP is linked to neurodegenerative disease.